Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches

Besides the broad development of nanotechnological approaches for cancer diagnosis and therapy, currently, there is no significant progress in the treatment of different types of brain tumors. Therapeutic molecules crossing the blood–brain barrier (BBB) and reaching an appropriate targeting ability...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitusova, Ksenia, Peltek, Oleksii O., Karpov, Timofey E., Muslimov, Albert R., Zyuzin, Mikhail V., Timin, Alexander S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479308/
https://www.ncbi.nlm.nih.gov/pubmed/36109754
http://dx.doi.org/10.1186/s12951-022-01610-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479308/
https://www.ncbi.nlm.nih.gov/pubmed/36109754
http://dx.doi.org/10.1186/s12951-022-01610-7

Ejemplares similares